ADEL
The company is a spin-off from Asan Medical Center, University of Ulsan University, with a primary objective of developing therapeutic and diagnostic agents for neurological diseases, particularly Alzheimer's disease. In 2016, the company took significant steps toward formalizing its presence in the market by completing its incorporation and business registration processes. The year 2017 proved to be a milestone for the company as it obtained certification as a corporate-affiliated research in... stitute, solidifying its position as a reputable research-driven organization. Additionally, it garnered recognition as a leading university start-up by the Ministry of SMEs and Startups, further boosting its credibility and potential for growth. The company has collaborated with Oscotech Co., Ltd. and partnered with various investors, including Kite Entrepreneurship Foundation, Stone Bridge Ventures Co., Ltd., Korea Development Bank, and Stick Ventures Co., Ltd., to jointly develop their projects.
ADEL
Social Links:
Industry:
Health Care Medical Pharmaceutical
Founded:
2016-01-01
Address:
Seoul, Seoul-t'ukpyolsi, South Korea
Country:
South Korea
Website Url:
http://www.adelpharm.com
Status:
Active
Contact:
+82 2-3010-4191
Email Addresses:
[email protected]
Technology used in webpage:
Person Schema Gravatar Profiles CrUX Top 50m CrUX Dataset
Similar Organizations
AnnJi Pharmaceutical
AnnJi Pharmaceutical is a drug development company that produces small molecules for neurology, dermatology, and inflammatory disorders.
Dongwha Pharm
Dongwha Pharm offers drugs such as antipyretics, analgesics, and antibiotics for cardiovascular, and alimentary ailments.
Immuno-Biological Laboratories
Immuno-Biological Laboratories is developing, manufacturing and supplying various immunological research reagents, and customized services.
YL-Pharma
YL-Pharma is a developer of small chemical drugs for the treatment of cancer, autoimmune diseases, and metabolic disorders.
Youdim Pharmaceuticals
Youdim Pharmaceuticals is a developer of therapeutic and diagnostic solutions for neurological disorders and cancer.
Investors List
STIC Ventures
STIC Ventures investment in Seed Round - ADEL
Official Site Inspections
http://www.adelpharm.com Semrush global rank: 5.59 M Semrush visits lastest month: 1.29 K
- Host name: 183.111.183.82
- IP address: 183.111.183.82
- Location: South Korea
- Latitude: 37.5112
- Longitude: 126.9741
- Timezone: Asia/Seoul
More informations about "ADEL"
ADEL - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +82 2-3010-4191 The company is a spin-off from Asan Medical Center, University of Ulsan …See details»
HOME - ADEL
HOME adelpharm 2024-08-21T11:22:48+09:00. We dream of a world without dementia. Alzheimer’s Disease Experts Lab ADEL,Inc. We dream of a world without dementia. Alzheimer’s Disease Experts Lab ADEL,Inc. Leading …See details»
HOME - ADEL
HOME adelpharm 2024-08-21T10:48:33+09:00. We dream of a world without dementia. Alzheimer’s Disease Experts Lab ADEL,Inc. We dream of a world without dementia. …See details»
Vision - ADEL - adelpharm.com
Company Vision Vision 1. Treatment and Diagnostic R & D Company for patients, families, and society suffering from Alzheimer's disease 2. A company that develops innovative platform …See details»
Adel (Drug Discovery) - PitchBook
Jan 1, 2018 Information on valuation, funding, cap tables, investors, and executives for Adel (Drug Discovery). Use the PitchBook Platform to explore …See details»
ADEL - Company Profile - Tracxn
Nov 16, 2024 ADEL ranks 41st among 89 active competitors. 26 of its competitors are funded while 10 have exited. Overall, ADEL and its competitors have raised over $1.4B in funding …See details»
ADEL, Inc. - VentureRadar
Adel is a Korean biotech company developing novel innovative approach to neurodegenerative diseases like Alzheimer and Parkinson diseases. ADTAC... ... Find out more ...See details»
ADEL - Products, Competitors, Financials, Employees, …
Adelpharm.com. Overview & Products; Financials; Founded Year 2016. Stage Bridge | Alive. Total Raised $12.44M. Last Raised $12.44M | 2 mos ago. Mosaic Score. The Mosaic Score is an …See details»
Adelpharm AG Company Profile | Adelboden, BERN, Switzerland ...
Find company research, competitor information, contact details & financial data for Adelpharm AG of Adelboden, BERN. Get the latest business insights from Dun & Bradstreet.See details»
ADEL, Inc. | Insights
Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Oscotec/ADEL Announce FDA Clearance of IND Application of …
PANGYO, South Korea, Sept. 14, 2023 /PRNewswire/ -- Oscotec Inc. and ADEL Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared the investigational new drug …See details»
Recruitment - ADEL
ADRESS. Headquarters : Dep of Brain Science, AMC, 88, Olympic-ro 43-gil, Songpa-gu, Seoul. Seongnae Lab : HANS building 3F & 5F, 90, Pungseong-ro, Gangdong-gu, SeoulSee details»
ADEL, Inc. - Facebook
ADEL, Inc. 51 likes. ADEL,inc. develops novel Alzheimer's disease therapeutics & diagnostics.See details»
ADEL, Inc. (ADEL, Inc.) - 药物管线_专利_临床试验_投融营收_最新药 …
了解adel, inc. (adel, inc.)公司的药物管线，治疗领域，技术平台，以及它的1项临床试, 2篇新闻和6篇文献，疾病领域:神经系统疾病，肿瘤，内分泌与代谢疾病，技术平台:单克隆抗体，小分子 …See details»
Medicines in Development Preventive Treatment and Chronic …
Drug Name Organization Indication Development Phase AL-001 Alzamend Neuro Alzheimer's disease Phase II (neuron modulator) Atlanta, GA www.alzamend.com AL001 (latozinemab) …See details»
비전 - ADEL
회사 비전 비전 1. 알츠하이머병으로 고통 받는 환자와 가족, 사회를 위한 치료·진단 연구개발 회사 2. 혁신적인 플랫폼 기술과 First-in-Class 신약을 개발하는 회사 3. 매출을 통해 생존하고 기술개발을 …See details»
Adelpharm AG | Apotheke Adelboden - Adelboden-Lenk-Kandersteg
Adelpharm AG | Apotheke Adelboden Dorfstrasse 16 3715 Adelboden. Route anzeigen (0041) 033 673 13 75 E-Mail senden Kontakt ...See details»
ADEL Y04 - AdisInsight - Springer
Dec 11, 2023 If your organization has a subscription, there are several access options, even while working remotely: Working within your organization’s network Login with …See details»
ADEL-D01 - ADEL
ADEL-D01 adelpharm 2023-10-27T15:45:43+09:00. Pipeline. ADEL-D01. HOME; PIPELINE; ADEL-D01; ADEL-D01. Tau pT217 antibody. Target Type. phosphorylated Tau (T217) …See details»
ADTAC™ - ADEL
ADTAC can degrade not only soluble proteins but also highly misfolded proteins or large-sized aggregates or lipids or even pathogens.; ADTAC can degrade damaged organelles; ADTAC is …See details»